AccuLine vs Immunarray
AccuLine vs Immunarray, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AccuLine is on 55/100 and Immunarray on 39/100.
Where each one leads
AccuLine
- our overall score: 55/100 against 39/100
- agent readiness: 50/100 against 28/100
- domain rating: 26/100 against 18/100
Immunarray
- funding raised: $10.0M against $5.5M
At a glance
| Measure | AccuLine | Immunarray |
|---|---|---|
| What it is | Developing CORA, a smart exam for early detection of coronary artery disease. | ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform. |
| Category | Healthcare, Biomarkers, Heart, Coronary Artery Disease | Healthcare, Blood, Diagnostics, Immunology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2022 | 2006 |
| Headquarters | Not published | Richmond, United States |
| Status | Inactive | Inactive |
Size, funding and growth
| Measure | AccuLine | Immunarray |
|---|---|---|
| Employees | 11 | Not published |
| Headcount growthLast 12 months | +19.0% | Not published |
| Total funding | $5.5M | $10.0M |
| Latest round | Seed | Series A |
| LinkedIn followers | 3,578 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AccuLine | Immunarray |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 39/100 |
| Traction | 44/100 | 35/100 |
| Team | 70/100 | 30/100 |
| Community | Not published | 13/100 |
| Search visibility | 33/100 | 5/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (28/100) |
| Domain ratingLink authority, 0-100 | 26/100 | 18/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AccuLine | Immunarray |
|---|---|---|
| Hosting | Google Cloud | Not detected |
AccuLine vs Immunarray: common questions
Which is better, AccuLine or Immunarray?
On our 0-100 score AccuLine rates higher (55/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do AccuLine and Immunarray compare on the numbers?
AccuLine leads on our overall score (55/100 against 39/100), agent readiness (50/100 against 28/100), domain rating (26/100 against 18/100). Immunarray leads on funding raised ($10.0M against $5.5M).
Read the full AccuLine review and pricing or the Immunarray review and pricing. You can also browse other AccuLine alternatives we track.